Nimodipine emulsion injection liquid and method for preparing the same

A technology of nimodipine milk and nimodipine, which is applied in the direction of emulsion delivery, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve the problems of hindering blood coagulation, prolonging the time of crystallization, general effect, etc., and achieve storage and Ease of use, enhanced solubility, stable content

Inactive Publication Date: 2006-02-15
SHANGHAI INST OF PHARMA IND +1
View PDF0 Cites 27 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When this preparation is used clinically, there is mainly the problem that the concentration is low (0.2mg/ml), crystals are easily precipitated when diluted, and non-aqueous solvents stimulate blood vessels to cause phlebitis. In addition, when used clinically, when using 5% glucose injection 2 to 3 hours after dilution, needle-like or columnar nimodipine crystals will appear, and the content will drop rapidly, which will directly affect the safety and effectivene

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0069] Example 1

[0070] Under the protection of nitrogen, weigh 50g of soybean oil for injection and heat it to 70°C, add 5g egg yolk lecithin, 0.1g nimodipine, and 0.5g benzyl alcohol under high-speed stirring, and stir evenly as the oil phase; use 10g glycerin for injection Add to 600ml water for injection, mix well and filter with 0.45μm filter membrane as the water phase. Add the oil phase to the water phase under high-speed stirring to make colostrum. Measure the pH value to be 6.0, add water for injection to 1000ml, repeat homogenization by a high-pressure homogenizer, check the size of the milk particles, and all the particles are less than 1μm in diameter. After the emulsion is filtered, it is filled and sealed with nitrogen, and sterilized by rotary steam. After cooling, the nimodipine emulsion injection is obtained after passing the inspection.

Example Embodiment

[0071] Example 2

[0072] Under the protection of nitrogen, weigh 300g of soybean oil for injection and heat it to 80℃. Under high-speed stirring, add 30g of egg yolk lecithin, 3g of nimodipine, and 50g of benzyl alcohol. Stir evenly as the oil phase; add 50g of glycerin for injection to 500ml In the water for injection, mix well and filter it with a 0.45μm filter membrane as the water phase. Add the oil phase to the water phase under high-speed stirring to make colostrum. Measure the pH value to 8.0, add water for injection to 1000ml, repeat homogenization with a high-pressure homogenizer, check the size of the milk particles, and all the particles are less than 1μm in diameter. After the emulsion is filtered, it is filled and sealed with nitrogen, and sterilized by rotary steam. Nimodipine emulsion injection is obtained after cooling.

Example Embodiment

[0073] Example 3

[0074] Under the protection of nitrogen, weigh 100g of soybean oil for injection and heat to 75℃. Under high-speed stirring, add 12g of egg yolk lecithin, 1g of nimodipine, and 10g of benzyl alcohol. Stir evenly as the oil phase; add 22.5g of glycerin for injection In 600ml of water for injection, mix well and filter with 0.45μm membrane filter as the water phase. Add the oil phase to the water phase under high-speed stirring to make colostrum. Measure the pH value to 7.0, add water for injection to 1000ml, and repeat the homogenization with a high-pressure homogenizer to check the size of the milk particles, and all the particles are less than 1μm in diameter. After the emulsion is filtered, it is filled and sealed with nitrogen, and sterilized by rotary steam. Nimodipine emulsion injection is obtained after cooling.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides a high concentration nimodipine emulsion injection for intravenous injection, which is prepared from active component of nimodipine and auxiliary materials including oil for injection, emulsifying agent, auxiliary solvent, isotonic conditioning agent and water for injection.

Description

technical field [0001] The invention relates to nimodipine emulsion injection for intravenous injection and a preparation method thereof. Background technique [0002] Nimodipine (Nimodipine) is a second-generation calcium antagonist. The drug acts preferentially on small arteries and selectively acts on cerebral blood vessels. It can significantly reduce cerebral hemorrhage damage and promote the recovery of nerve function. It is clinically used for ischemic The treatment of cerebrovascular disease, migraine, sudden deafness, subarachnoid cerebral hemorrhage and hypertension has achieved good therapeutic effect. [0003] Nimodipine is a poorly soluble drug that is soluble in ethanol, ether and other organic solvents but insoluble in water. Nimodipine injections currently on the market are made into non-aqueous solvent injections, which contain a large amount of ethanol (20-25%) and polyethylene glycol (17-20%) as solvents. When this preparation is used clinically, there i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4422A61K9/107A61P9/10A61P25/06A61P9/12
Inventor 谢保源张锡昌陆敏张喜全陈允发张来芳张兵王林晏彩霞蔡紫阳
Owner SHANGHAI INST OF PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap